696 related articles for article (PubMed ID: 26248154)
61. CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
Wang Y; Zhao HW; Zhang XJ; Chen BJ; Yu GN; Hou AJ; Luan B
BMC Cardiovasc Disord; 2019 Mar; 19(1):74. PubMed ID: 30922230
[TBL] [Abstract][Full Text] [Related]
62. Kidney function estimating equations in patients with chronic kidney disease.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Int J Clin Pract; 2011 Apr; 65(4):458-64. PubMed ID: 21401834
[TBL] [Abstract][Full Text] [Related]
63. [Prospective evaluation of renal function by serum cystatin-C: comparison with three other parameters of glomerular filtration rate].
Tamba K; Kusano E; Ando Y; Asano Y
Nihon Jinzo Gakkai Shi; 2001 Nov; 43(8):646-50. PubMed ID: 11808075
[TBL] [Abstract][Full Text] [Related]
64. Simple cystatin C formula compared to sophisticated CKD-EPI formulas for estimation of glomerular filtration rate in the elderly.
Bevc S; Hojs R; Ekart R; Gorenjak M; Puklavec L
Ther Apher Dial; 2011 Jun; 15(3):261-8. PubMed ID: 21624073
[TBL] [Abstract][Full Text] [Related]
65. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
Bilasy ME; Oraby MA; Ismail HM; Maklady FA
J Interv Cardiol; 2012 Aug; 25(4):404-10. PubMed ID: 22612071
[TBL] [Abstract][Full Text] [Related]
66. Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.
Chousterman BG; Bouadma L; Moutereau S; Loric S; Alvarez-Gonzalez A; Mekontso-Dessap A; Laissy JP; Rahmouni A; Katsahian S; Brochard L; Schortgen F
J Crit Care; 2013 Oct; 28(5):701-9. PubMed ID: 23683568
[TBL] [Abstract][Full Text] [Related]
67. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
Chong E; Shen L; Poh KK; Tan HC
Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
[TBL] [Abstract][Full Text] [Related]
68. Coronary computed tomography angiography - tolerability of β-blockers and contrast media, and temporal changes in radiation dose.
Pedersen C; Thomsen CF; Hosbond SE; Thomassen A; Mickley H; Diederichsen AC
Scand Cardiovasc J; 2014 Oct; 48(5):271-7. PubMed ID: 25100617
[TBL] [Abstract][Full Text] [Related]
69. Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.
Uddin MA; Rabbani MA; Jafary FH; Bhatti MA; Islam M
J Coll Physicians Surg Pak; 2005 Dec; 15(12):791-4. PubMed ID: 16398973
[TBL] [Abstract][Full Text] [Related]
70. N-acetylcysteine in preventing contrast-induced nephropathy assessed by cystatin C.
Alioglu E; Saygi S; Turk U; Kirilmaz B; Tuzun N; Duman C; Tengiz I; Yildiz S; Ercan E
Cardiovasc Ther; 2013 Jun; 31(3):168-73. PubMed ID: 22212518
[TBL] [Abstract][Full Text] [Related]
71. Brain natriuretic peptide for prevention of contrast-induced nephropathy after percutaneous coronary intervention or coronary angiography.
Liu JM; Xie YN; Gao ZH; Zu XG; Li YJ; Hao YM; Chang L
Can J Cardiol; 2014 Dec; 30(12):1607-12. PubMed ID: 25418218
[TBL] [Abstract][Full Text] [Related]
72. Serum cystatin c is not superior to serum creatinine for early diagnosis of contrast-induced nephropathy in patients who underwent angiography.
Xu Q; Wang NN; Duan SB; Liu N; Lei R; Cheng W; Zhou SK
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27897324
[TBL] [Abstract][Full Text] [Related]
73. Cystatin C as a predictive marker of renal dysfunction and mid-term outcomes following off-pump coronary artery bypass grafting.
Lee SH; Youn YN; Choo HC; Lee S; Yoo KJ
Heart; 2015 Oct; 101(19):1562-8. PubMed ID: 26215986
[TBL] [Abstract][Full Text] [Related]
74. Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
Kurtul A; Yarlioglues M; Murat SN; Demircelik MB; Acikgoz SK; Ergun G; Duran M; Cetin M; Ornek E
Angiology; 2015 May; 66(5):433-40. PubMed ID: 24834929
[TBL] [Abstract][Full Text] [Related]
75. Is cystatin-C superior to creatinine in the early diagnosis of contrast-induced nephropathy?: a potential new biomarker for an old complication.
Ebru AE; Kilic A; Korkmaz FS; Seker R; Sasmaz H; Demirtas S; Biyikli Z
J Postgrad Med; 2014; 60(2):135-40. PubMed ID: 24823511
[TBL] [Abstract][Full Text] [Related]
76. Preoperative serum cystatin C combined with dipstick proteinuria predicts acute kidney injury after cardiac surgery.
Wang X; Che M; Xie B; Xue S; Yan Y
Ren Fail; 2014 Nov; 36(10):1497-503. PubMed ID: 25155186
[TBL] [Abstract][Full Text] [Related]
77. Insulin Resistance Increases the Risk of Contrast-Induced Nephropathy in Patients Undergoing Elective Coronary Intervention.
Li Y; Liu Y; Shi D; Yang L; Liang J; Zhou Y
Angiology; 2016 Feb; 67(2):139-45. PubMed ID: 25843952
[TBL] [Abstract][Full Text] [Related]
78. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure.
Kuhn MJ; Chen N; Sahani DV; Reimer D; van Beek EJ; Heiken JP; So GJ
AJR Am J Roentgenol; 2008 Jul; 191(1):151-7. PubMed ID: 18562739
[TBL] [Abstract][Full Text] [Related]
79. β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease.
Joosten MM; Pai JK; Bertoia ML; Gansevoort RT; Bakker SJ; Cooke JP; Rimm EB; Mukamal KJ
J Am Heart Assoc; 2014 Jun; 3(4):. PubMed ID: 24980133
[TBL] [Abstract][Full Text] [Related]
80. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.
Toprak O; Cirit M; Esi E; Postaci N; Yesil M; Bayata S
Catheter Cardiovasc Interv; 2006 Feb; 67(2):227-35. PubMed ID: 16400673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
